title: [Breast cancer in young patient in Morrocco].
abstract: OBJECTIVE
  The aim of this retrospective study is to determine the epidemiological, clinical, therapeutic aspects and prognostic factors of breast cancer in women through a comparative study of 648 patients treated for breast cancer: 165 patients are at 35 years of age or less (G 1), 286 patients are more than 35 years old and non menopausal (G 2).
  
  
  METHODS
  We have collected, for each group, the epidemioclinical data. Nonmetastatic and operable cancer was treated by surgery (conservative or radical) followed by an adjuvant treatment (chemotherapy, radiotherapy, hormomotherapy) that was indicated according to prognosis factors. Locally advanced forms or metastatic at the moment of diagnosis were treated firstly by chemotherapy.
  
  
  RESULTS
  T2N1 forms with lymph node involvement, high grade (SBR II, III) and negative hormonal receptors (HR-) were predominant. There was no difference between the two groups of women concerning risk factors or clinical criterias, except for the mammography that was more sensible in the second group.
  
  
  CONCLUSIONS
  The breast cancer in our young patient doesn't seem to be different from the older ones either in clinical presentation or evolution. The conclusions of different authors are divergent but they are all for evoluated forms with more defavorable prognosis than in the older women.
authors.affiliation: Service de gynécologie-obstétrique C, CHU Ibn Rochd de Casablanca, 1, rue des Hôpitaux-ex Banaflous, 20360 Casablanca, Maroc. mohcineb@yahoo.fr
authors.forename: H
authors.initials: H
authors.lastname: Boufettal
authors.forename: M
authors.initials: M
authors.lastname: Noun
authors.forename: N
authors.initials: N
authors.lastname: Samouh
mesh_terms: D000328:Adult; D017668:Age of Onset; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000000981:diagnostic imaging / Q000453:epidemiology* / Q000473:pathology / Q000628:therapy; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D004967:Estrogens; D005260:Female; D006801:Humans; D008327:Mammography; D008408:Mastectomy; D008875:Middle Aged; D009018:Morocco / Q000453:epidemiology; D009367:Neoplasm Staging; D009376:Neoplasms, Hormone-Dependent / Q000000981:diagnostic imaging / Q000453:epidemiology / Q000473:pathology / Q000628:therapy; D017697:Premenopause; D011374:Progesterone; D011379:Prognosis; D018714:Radiotherapy, Adjuvant; D011960:Receptors, Estrogen / Q000032:analysis; D011980:Receptors, Progesterone / Q000032:analysis; D012189:Retrospective Studies; D012307:Risk Factors; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D004967:Estrogens; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D011374:Progesterone